Evidence Hub

AQbD-Guided Chiral HPLC for Enantiomeric Impurity Analysis of Suzetrigine

Alhunayhin SMN, Algohary AM, Althobaiti SA, Alluhayb AH, Shahin MI, Ibrahim AM, Hasanin THA

Chirality, 2026

1 citation

Abstract

ABSTRACT Suzetrigine (SUZ), an analgesic for acute pain, requires strict enantiomeric purity control. This study develops a robust chiral HPLC method for SUZ and its R‐enantiomer using analytical quality by design (AQbD). Separation was achieved on a Chiralpak IC‐3 column with an isocratic n‐hexane–ethanol (90:10, v/v) mobile phase. The optimized method provided baseline resolution ( R s = 3.0) in 15 min. Validation via the accuracy profile approach confirmed reliable quantification, with limits of 290 μg mL −1 (SUZ) and 0.32 μg mL −1 (R‐enantiomer). The AQbD strategy defined a method operable design region (MODR) ensuring robust routine performance. Furthermore, multimetric sustainability assessments demonstrated a favorable environmental profile, yielding blue applicability grade index (BAGI) and mosaic‐WAC scores of 77.5 and 73.2, respectively. This approach enables reliable, eco‐friendly enantiomeric purity assessment of SUZ in bulk and pharmaceutical formulations.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free